Latest News about Psychedelic Research
Recent news which mentions Psychedelic Research
From Benzinga
Psychedelics 2.0: Companies Explore Safer, More Targeted Therapies
October 04, 2024
From Benzinga
Long-Term Medical Cannabis Use Has No Significant Harmful Effects On Memory Or Impulse Control, New Study Says
September 23, 2024
From Benzinga
Ultra-Low-Dose Ketamine May Offer Relief For Opioid Withdrawal, Study Finds
September 18, 2024
From Benzinga
Magic Mushrooms Boosted Humanity's Evolutionary Success, New Study Says: Did Psilocybin Make Early Humans Better Hunters?
September 13, 2024
From Benzinga
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
September 12, 2024
From Benzinga
LSD, MDMA And d-Amphetamine: Study Provides New Insights Into Neurobiological Effects
September 12, 2024
From Benzinga
PharmAla Biotech Partners With Johns Hopkins University For MDMA Clinical Trials, Terminates Red Light Holland Contract
September 11, 2024
From Benzinga
Moxy: The Short, Intense Psychedelic High Sweeping The Globe
September 10, 2024
From Benzinga
Psilocybin Drug By Psilera Could Treat Frontotemporal Dementia Without Psychoactive Effects
September 09, 2024
Tickers
NEWS
From Benzinga
How Set And Setting Impact The Effects Of LSD, New Study Sheds Light
September 05, 2024
Tickers
NEWS
From Benzinga
Psychedelic Therapy Needs To Move Beyond Mystical Experiences, Say Researchers In New Study
September 03, 2024
Tickers
NEWS
From Benzinga
Single-Dose Psilocybin Therapy Shows Promise For Treating Alcohol Use Disorder, Study Finds
August 30, 2024
From Benzinga
Multidisciplinary Association For Psychedelic Studies Funds MDMA-Assisted Therapy Trial For PTSD
August 29, 2024
From Benzinga
Psychedelic Trips Resemble Near-Death Experiences, New Study Shows—What Does It Mean?
August 23, 2024
From Benzinga
LSD's Potential In Pain Management: New Research Sheds Light On Psychedelic's Influence On Brain Networks
August 21, 2024
Tickers
NEWS
From Benzinga
From Benzinga
From Benzinga
FDA Clears Incannex To Proceed With Phase 2 Psilocybin-Assisted Therapy Trial For Anxiety
August 05, 2024
Tickers
IXHL
From Benzinga
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
February 15, 2024
From Benzinga
Can Psychedelics Increase Sexual Interest And Satisfaction? Study Says Yes And Effects Can Last Months
February 14, 2024
Tickers
NEWS
From Benzinga
US Universities Ride The Psychedelics Wave With New Programs In Their Medical Schools
February 06, 2023
From Benzinga
Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project
December 06, 2022
From Benzinga
EXCLUSIVE: MAPS To Host Major Psychedelics Event In 2023, Speakers & Details Below
December 01, 2022
Tickers
MAPS
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
